The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pancreatic metastases from renal cell carcinoma: Prognostic relevance and outcome in patients treated with targeted agents.
 
Paolo Grassi
No Relationships to Disclose
 
Ludovic S. Doucet
No Relationships to Disclose
 
Palma Giglione
No Relationships to Disclose
 
Viktor Gruenwald
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; GlaxoSmithKline; MOLOGEN; Pfizer
 
Bohuslav Melichar
Honoraria - Bayer; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Bayer; Novartis; Pfizer; Roche Pharma AG
 
Luca Galli
No Relationships to Disclose
 
Ugo De Giorgi
No Relationships to Disclose
 
Annalisa Guida
No Relationships to Disclose
 
Cinzia Ortega
Honoraria - Bayer
Consulting or Advisory Role - GlaxoSmithKline
 
Matteo Santoni
No Relationships to Disclose
 
Aristotelis Bamias
No Relationships to Disclose
 
Elena Verzoni
No Relationships to Disclose
 
Andrea Necchi
No Relationships to Disclose
 
Lisa Derosa
No Relationships to Disclose
 
Hana Studentova
No Relationships to Disclose
 
Monica Pacifici
No Relationships to Disclose
 
Filippo G. De Braud
No Relationships to Disclose
 
Camillo Porta
No Relationships to Disclose
 
Bernard J. Escudier
No Relationships to Disclose
 
Giuseppe Procopio
Honoraria - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Novartis; Pfizer